Galenus von Pergamon Prize 2021-Candidates Leqvio® - first siRNA for the Ttreatment of Hypercholesterolemia

被引：0

|

作者：

不详

机构：

来源：

MONATSSCHRIFT KINDERHEILKUNDE | 2021年 / 169卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

收藏

页码：901 / 901

页数：1

相关论文

共 39 条

[1] Galenus von Pergamon Prize 2022-the candidates
不详
GYNAKOLOGIE, 2022, 55 (09): : 707 - 707
[2] Galenus von Pergamon Prize 2022-the candidates
不详
MONATSSCHRIFT KINDERHEILKUNDE, 2022, 170 (10) : 936 - 936
[3] Galenus-von Pergamon Prize 2021-Candidates Zolgensma® - Single-Use Gene Therapy for the Treatment of Spinal Muscular Atrophy
不详
MONATSSCHRIFT KINDERHEILKUNDE, 2021, 169 (10) : 970 - 970
[4] Galenus von Pergamon Prize 2021-the Candidates Kaftrio® - Triple Combination in Cystic Fibrosis
不详
MONATSSCHRIFT KINDERHEILKUNDE, 2021, 169 (09) : 855 - 855
[5] Galenus von Pergamon Prize 2021-The Candidates Sunosi® - longer alert with excessive Daytime Sleepiness
不详
NERVENARZT, 2021, 92 (10): : 1074 - 1074
[6] Galenus-von-Pergamon Prize 2021 - The candidates. Givlaari® - first and only Treatment for Patients with acute hepatic Porphyria
不详
NEPHROLOGE, 2021, 16 (05): : 291 - 291
[7] Galenus von Pergamon Prize 2021-the Candidates Urothelial Carcinoma: Antibody Bavencio® promotes longer Survival
不详
ONKOLOGE, 2021, 27 (09): : 875 - 875
[8] Galenus von Pergamon Prize 2023-the Candidates Pluvicto® - The first Radioligand Therapy for Prostate Cancer
不详
RADIOLOGIE, 2023, 63 (07): : 542 - 542
[9] Galenus von Pergamon Prize 2023-the Candidates Pluvicto® - The first Radioligand Therapy for Prostate Cancer
不详
UROLOGIE, 2023, 62 (07): : 684 - 684
[10] Galenus von Pergamon Prize 2021-the Candidates Poteligeo® slows Tumor Progression in Mycosis fungoides and Sezary Syndrome
不详
ONKOLOGE, 2021, 27 (09): : 910 - 910

← 1 2 3 4 →